The Breakthrough T1D Northern California Center of Excellence is a cure accelerator and a high-impact partnership between UCSF and Stanford University, supported by Breakthrough T1D (formerly JDRF).
MISSION
Breakthrough T1D Northern California Center of Excellence aims to promote collaborative efforts among type 1 diabetes (T1D) researchers at the University of California, San Francisco (UCSF) and Stanford University School of Medicine co-led by Drs. Qizhi Tang and Seung Kim. We aim to accelerate research progress by integrating the expertise of T1D investigators at these two institutions. Our overall goal is to expand the basic research foundations to inform the design of more effective cell-based therapies for T1D. This work will uniquely benefit from the diverse and complementary expertise of the investigators at UCSF and Stanford to address important and unresolved questions in T1D biology with the intent of translating the findings into novel therapies.
RESEARCH
Probing T1D Pathogenesis
Project 1
Engineering Immune Tolerance
Project 2
Project 3
Building Vascular Niche-Enhanced Islets
CORES
Admin Core
Stem Cell Core
Animal Core
NEWS & EVENTS
BT1D NorCal CoE Events
-
Join us for exciting talks from trainees in the NorCal CoE - second friday of every month.
Nov 2025 Meeting -
UCSF Speaker: TBD, PhD, Postdoctoral Fellow, Bhushan Lab
Presentation Topic: TBD
-
BT1D Kick-off Event
Oct 24th
Lokey Stem Cell Research Building, 265 Campus Drive, Stanford, CA 94305
Room# G1002
-
October 7, 2019, 9:30am - 4:00pm
UCSF Aldea Center
BT1D News
-
BT1D NorCAL investigators celebrate the 2025 Nobel Prize of Physiology and Medicine awarded to Drs. Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their discovery of Tregs.
-
-
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!